Comparison of Edwards SAPIEN 3 versus SAPIEN XT in transfemoral transcatheter aortic valve implantation: Difference of valve selection in the real world

Journal of Cardiology

Volumn 69, Issue 3, 2017, Pages 565-569

  Arai, Takahide ^a   Lefèvre, Thierry ^a   Hovasse, Thomas ^a   Morice, Marie Claude ^a   Garot, Philippe ^a   Benamer, Hakim ^a   Unterseeh, Thierry ^a   Hayashida, Kentaro ^a,b   Watanabe, Yusuke ^a,c   Bouvier, Erik ^a   Cormier, Bertrand ^a   Chevalier, Bernard ^a  

^a INSTITUT CARDIOVASCULAIRE PARIS SUD   (France)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

SAPIEN 3; SAPIEN XT; Severe symptomatic aortic stenosis; Transcatheter aortic valve implantation

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; WARFARIN;

ACUTE KIDNEY FAILURE; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY; DUAL ANTIPLATELET THERAPY; EUROSCORE; FEMALE; HIGH RISK PATIENT; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIDETECTOR COMPUTED TOMOGRAPHY; PACEMAKER IMPLANTATION; PARAVALVULAR LEAK; PERCUTANEOUS AORTIC VALVE; SURVIVAL; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSTHORACIC ECHOCARDIOGRAPHY; ADVERSE EFFECTS; AGED; AORTIC VALVE; AORTIC VALVE STENOSIS; COMPARATIVE STUDY; HEART VALVE PROSTHESIS; POSTOPERATIVE COMPLICATION; PROSTHESIS COMPLICATION; PROSTHESIS DESIGN; RISK FACTOR; TREATMENT OUTCOME;

AGED; AORTIC VALVE; AORTIC VALVE STENOSIS; FEMALE; HEART VALVE PROSTHESIS; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; PROSTHESIS DESIGN; PROSTHESIS FAILURE; RISK FACTORS; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME;

EID: 84973582170     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2016.04.012     Document Type: Article

References (24)

1. [1] Zahn, R., Gerckens, U., Grube, E., Linke, A., Sievert, H., Eggebrecht, H., Hambrecht, R., Sack, S., Hauptmann, K.E., Richardt, G., Figulla, H.R., Senges, J., German Transcatheter Aortic Valve Interventions-Registry Investigators. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J 32 (2011), 198–204.
2. [2] Moat, N.E., Ludman, P., de Belder, M.A., Bridgewater, B., Cunningham, A.D., Young, C.P., Thomas, M., Kovac, J., Spyt, T., MacCarthy, P.A., Wendler, O., Hildick-Smith, D., Davies, S.W., Trivedi, U., Blackman, D.J., et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol 58 (2011), 2130–2138.
3. [3] Webb, J., Cribier, A., Percutaneous transarterial aortic valve implantation: what do we know?. Eur Heart J 32 (2011), 140–147.
4. [4] Leon, M.B., Smith, C.R., Mack, M., Miller, D.C., Moses, J.W., Svensson, L.G., Tuzcu, E.M., Webb, J.G., Fontana, G.P., Makkar, R.R., Brown, D.L., Block, P.C., Guyton, R.A., Pichard, A.D., Bavaria, J.E., et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363 (2010), 1597–1607.
5. [5] Lefevre, T., Kappetein, A.P., Wolner, E., Nataf, P., Thomas, M., Schachinger, V., De Bruyne, B., Eltchaninoff, H., Thielmann, M., Himbert, D., Romano, M., Serruys, P., Wimmer-Greinecker, G., PARTNER EU Investigator Group. One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J 32 (2011), 148–157.
6. [6] Arai, T., Lefevre, T., Who is the right patient for TAVI?. J Cardiol 63 (2014), 178–181.
7. [7] Wendt, D., Al-Rashid, F., Kahlert, P., El-Chilali, K., Demircioglu, E., Neuhauser, M., Liakopoulos, O., Sebastian Dohle, D., Erbel, R., Jakob, H., Thielmann, M., Conventional aortic valve replacement or transcatheter aortic valve implantation in patients with previous cardiac surgery. J Cardiol 66 (2015), 292–297.
8. [8] Abdel-Wahab, M., Zahn, R., Horack, M., Gerckens, U., Schuler, G., Sievert, H., Eggebrecht, H., Senges, J., Richardt, G., German Transcatheter Aortic Valve Interventions Registry Investigators. Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry. Heart 97 (2011), 899–906.
9. [9] Van Belle, E., Juthier, F., Susen, S., Vincentelli, A., Iung, B., Dallongeville, J., Eltchaninoff, H., Laskar, M., Leprince, P., Lievre, M., Banfi, C., Auffray, J.L., Delhaye, C., Donzeau-Gouge, P., Chevreul, K., et al. Postprocedural aortic regurgitation in balloon-expandable and self-expandable transcatheter aortic valve replacement procedures: analysis of predictors and impact on long-term mortality: insights from the FRANCE2 Registry. Circulation 129 (2014), 1415–1427.
10. [10] Toggweiler, S., Leipsic, J., Binder, R.K., Freeman, M., Barbanti, M., Heijmen, R.H., Wood, D.A., Webb, J.G., Management of vascular access in transcatheter aortic valve replacement: Part 2: Vascular complications. JACC Cardiovasc Interv 6 (2013), 767–776.
11. [11] Binder, R.K., Rodes-Cabau, J., Wood, D.A., Mok, M., Leipsic, J., De Larochelliere, R., Toggweiler, S., Dumont, E., Freeman, M., Willson, A.B., Webb, J.G., Transcatheter aortic valve replacement with the SAPIEN 3: a new balloon-expandable transcatheter heart valve. JACC Cardiovasc Interv 6 (2013), 293–300.
12. [12] Yang, T.H., Webb, J.G., Blanke, P., Dvir, D., Hansson, N.C., Norgaard, B.L., Thompson, C.R., Thomas, M., Wendler, O., Vahanian, A., Himbert, D., Kodali, S.K., Hahn, R.T., Thourani, V.H., Schymik, G., et al. Incidence and severity of paravalvular aortic regurgitation with multidetector computed tomography nominal area oversizing or undersizing after transcatheter heart valve replacement with the Sapien 3: a comparison with the Sapien XT. JACC Cardiovasc Interv 8 (2015), 462–471.
13. [13] Hayashida, K., Lefevre, T., Chevalier, B., Hovasse, T., Romano, M., Garot, P., Mylotte, D., Uribe, J., Farge, A., Donzeau-Gouge, P., Bouvier, E., Cormier, B., Morice, M.C., Transfemoral aortic valve implantation new criteria to predict vascular complications. JACC Cardiovasc Interv 4 (2011), 851–858.
14. [14] Zamorano, J.L., Badano, L.P., Bruce, C., Chan, K.L., Goncalves, A., Hahn, R.T., Keane, M.G., La Canna, G., Monaghan, M.J., Nihoyannopoulos, P., Silvestry, F.E., Vanoverschelde, J.L., Gillam, L.D., EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. Eur Heart J 32 (2011), 2189–2214.
15. [15] Kappetein, A.P., Head, S.J., Genereux, P., Piazza, N., van Mieghem, N.M., Blackstone, E.H., Brott, T.G., Cohen, D.J., Cutlip, D.E., van Es, G.A., Hahn, R.T., Kirtane, A.J., Krucoff, M.W., Kodali, S., Mack, M.J., et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J 33 (2012), 2403–2418.
16. [16] Amat-Santos, I.J., Dahou, A., Webb, J., Dvir, D., Dumesnil, J.G., Allende, R., Ribeiro, H.B., Urena, M., Paradis, J.M., DeLarochelliere, R., Dumont, E., Bergeron, S., Thompson, C.R., Pasian, S., Bilodeau, S., et al. Comparison of hemodynamic performance of the balloon-expandable SAPIEN 3 versus SAPIEN XT transcatheter valve. Am J Cardiol 114 (2014), 1075–1082.
17. [17] Athappan, G., Patvardhan, E., Tuzcu, E.M., Svensson, L.G., Lemos, P.A., Fraccaro, C., Tarantini, G., Sinning, J.M., Nickenig, G., Capodanno, D., Tamburino, C., Latib, A., Colombo, A., Kapadia, S.R., Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol 61 (2013), 1585–1595.
18. [18] Kodali, S.K., Williams, M.R., Smith, C.R., Svensson, L.G., Webb, J.G., Makkar, R.R., Fontana, G.P., Dewey, T.M., Thourani, V.H., Pichard, A.D., Fischbein, M., Szeto, W.Y., Lim, S., Greason, K.L., Teirstein, P.S., et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 366 (2012), 1686–1695.
19. [19] Hayashida, K., Lefevre, T., Chevalier, B., Hovasse, T., Romano, M., Garot, P., Bouvier, E., Farge, A., Donzeau-Gouge, P., Cormier, B., Morice, M.C., Impact of post-procedural aortic regurgitation on mortality after transcatheter aortic valve implantation. JACC Cardiovasc Interv 5 (2012), 1247–1256.
20. [20] Watanabe, Y., Lefevre, T., Arai, T., Hayashida, K., Bouvier, E., Hovasse, T., Romano, M., Chevalier, B., Garot, P., Donzeau-Gouge, P., Farge, A., Cormier, B., Morice, M.C., Can we predict post-procedural paravalvular leak after Edwards Sapien transcatheter aortic valve implantation?. Catheter Cardiovasc Interv 86 (2015), 144–145.
21. [21] Ducrocq, G., Francis, F., Serfaty, J.M., Himbert, D., Maury, J.M., Pasi, N., Marouene, S., Provenchere, S., Iung, B., Castier, Y., Leseche, G., Vahanian, A., Vascular complications of transfemoral aortic valve implantation with the Edwards SAPIEN prosthesis: incidence and impact on outcome. EuroIntervention 5 (2010), 666–672.
22. [22] Eltchaninoff, H., Prat, A., Gilard, M., Leguerrier, A., Blanchard, D., Fournial, G., Iung, B., Donzeau-Gouge, P., Tribouilloy, C., Debrux, J.L., Pavie, A., Gueret, P., FRANCE Registry Investigators. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J 32 (2011), 191–197.
23. [23] Tarantini, G., Mojoli, M., Purita, P., Napodano, M., D'Onofrio, A., Frigo, A., Covolo, E., Facchin, M., Isabella, G., Gerosa, G., Iliceto, S., Unravelling the (arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve. EuroIntervention 11 (2015), 343–350.
24. [24] Del Trigo, M., Munoz-Garcia, A.J., Wijeysundera, H.C., Nombela-Franco, L., Cheema, A.N., Gutierrez, E., Serra, V., Kefer, J., Amat-Santos, I.J., Benitez, L.M., Mewa, J., Jimenez-Quevedo, P., Alnasser, S., Garcia Del Blanco, B., Dager, A., et al. Incidence, timing, and predictors of valve hemodynamic deterioration after transcatheter aortic valve replacement: multicenter registry. J Am Coll Cardiol 67 (2016), 644–655.